PMID- 34985210 OWN - NLM STAT- MEDLINE DCOM- 20220106 LR - 20220915 IS - 1872-2059 (Electronic) IS - 1000-8713 (Print) IS - 1000-8713 (Linking) VI - 40 IP - 1 DP - 2022 Jan TI - [Preparation of molecularly imprinted polymers based on covalent organic frameworks and their application to selective recognition of trace norfloxacin in milk]. PG - 1-9 LID - 10.3724/SP.J.1123.2021.03013 [doi] AB - Norfloxacin (NFX) is an antibiotic that is widely used in animal husbandry. However, the presence of NFX even in trace amounts in animal-derived food may harm human health. Therefore, it is of practical significance to establish a method for monitoring NFX residues in food. Molecularly imprinted polymers (MIPs) imitate interactions established by natural receptors to selectively retain a target molecule, like antibodies or antigens do. MIPs have been widely employed in the selective recognition of specific target molecules from complex samples. Covalent organic frameworks (COFs) are a new type of organic polymer with uniform and ordered crystal structures. COFs form crystal structures by constructing organic units for ordered assembly through reversible chemical reactions. Their porous structure, regular morphology, and easy modification make COFs promising for use as excellent adsorbent carriers. Owing to these advantages of COFs, researchers have attempted to coat one MIP layer on COFs; however, the preparation methods are time-consuming and laborious, and the conditions are harsh. Hence, this study proposes a simple and rapid method for the preparation of novel MIPs with COFs as the support (DP-COF@MIPs) for the selective recognition of NFX. First, a Schiff-base COF (DP-COF) was rapidly synthesized using 3,3'-diaminobenzidine and p-phthalaldehyde with a metal trifluorate as a catalyst at room temperature. Subsequently, a two-step sequence was adopted as the synthesis strategy using NFX as the template, methacrylic acid as a functional monomer, and ethylene glycol dimethacrylate as a crosslinking agent. The entire synthesis was completed within 5 h under mild conditions. The material was then characterized by multiple analytical methods, including field-emission scanning electron microscopy, Fourier-transform infrared spectroscopy, X-ray diffraction, and the Brunauer-Emmett-Teller (BET) method (to determine the specific surface area). The experimental results confirmed the successful preparation of DP-COF@MIPs. The DP-COF@MIPs presented a rough and porous surface, with a pore size of approximately 17.79 nm (mesoporous structure). The properties of the material were evaluated by adsorption and regeneration experiments. The kinetic adsorption experiment showed that the DP-COF@MIPs reached adsorption equilibrium in 90 min. Two straight lines were fitted using the pseudo-second-order kinetics model based on the experimental results for thermodynamic adsorption, indicating that the adsorption process was primarily dominated by chemical adsorption. The maximum apparent adsorption capacity was 41.57 mg/g. In the selective and competitive binding test, five drugs, namely ciprofloxacin, dimetridazole, oxytetracycline, sulfadiazine, and chloramphenicol, were selected as the interferents. The experimental results showed that the DP-COF@MIPs possessed good stereoselectivity and competitive recognition ability. The regeneration of DP-COF@MIPs was evaluated by multiple cycles of adsorption-desorption experiments. The loss in the adsorption capacity of the particles was only approximately 4.7% after seven adsorption-desorption cycles. These results from the regeneration experiments show that the DP-COF@MIPs had high stability and reusability in the selective adsorption and separation of NFX. In addition, the employed method could accurately identify trace NFX in milk samples. The average recoveries were in the range of 88.8%-92.9% at three spiked levels (0.03, 0.10, and 0.30 mg/L) with relative standard deviations (RSDs) in the range of 0.6-1.7% (n=3). Notably, the method could successfully determine NFX at contents as low as 0.0020 mg/L in the milk sample with an average recovery of 77.6% and RSD of 6.4% (n=3). This concentration is one-fiftieth of the maximum residue level stipulated by the European Union (EU), and even lower than the limit of detection (LOD) of conventional high performance liquid chromatography (HPLC) methods. The above results confirm that DP-COF@MIPs can be used to determine trace NFX in actual complex samples using HPLC equipment, even when coupled to conventional UV-Vis detectors. This study offers a facile and general method for the preparation of MIPs based on COFs with selective recognition ability. FAU - Xie, Yang AU - Xie Y AD - School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. FAU - Zhang, Yi AU - Zhang Y AD - School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. FAU - Shi, Haizhu AU - Shi H AD - School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. FAU - Wu, Zhaoju AU - Wu Z AD - School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. FAU - Yu, Xuehong AU - Yu X AD - School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. FAU - Zhang, Chungu AU - Zhang C AD - School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. FAU - Feng, Shun AU - Feng S AD - School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. LA - chi PT - Journal Article PL - China TA - Se Pu JT - Se pu = Chinese journal of chromatography JID - 9424804 RN - 0 (Metal-Organic Frameworks) RN - 0 (Molecularly Imprinted Polymers) RN - N0F8P22L1P (Norfloxacin) SB - IM MH - Adsorption MH - Animals MH - Humans MH - *Metal-Organic Frameworks MH - Milk MH - *Molecular Imprinting MH - Molecularly Imprinted Polymers MH - Norfloxacin PMC - PMC9404097 OTO - NOTNLM OT - covalent organic framework (COF) OT - molecularly imprinted polymer (MIP) OT - norfloxacin OT - trace residue EDAT- 2022/01/06 06:00 MHDA- 2022/01/07 06:00 PMCR- 2022/01/08 CRDT- 2022/01/05 08:58 PHST- 2022/01/05 08:58 [entrez] PHST- 2022/01/06 06:00 [pubmed] PHST- 2022/01/07 06:00 [medline] PHST- 2022/01/08 00:00 [pmc-release] AID - 1000-8713-40-1-1 [pii] AID - 10.3724/SP.J.1123.2021.03013 [doi] PST - ppublish SO - Se Pu. 2022 Jan;40(1):1-9. doi: 10.3724/SP.J.1123.2021.03013.